# OnCo record gemini-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/gemini-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "gemini-therapeutics" ;
  schema:name "Gemini Therapeutics"@en ;
  schema:alternateName "Gemini Thera"@en ;
  schema:description "Gemini Therapeutics is a startup with a single purpose: finishing the development of aldoxorubicin, a tumour-targeted form of doxorubicin, founded after the GitLab co-founder Sid Sijbrandij was treated with doxorubicin for osteosarcoma."@en ;
  schema:url <https://onco.cc/companies/gemini-therapeutics/>, <https://www.geminithera.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.geminithera.com>, <https://www.geminithera.com/team.html>, <https://www.geminithera.com/news/asco-2026-aldoxorubicin.html>, <https://x.com/GeminiThera> ;
  onco:tag "ctgov-sponsor", "startup", "owner-request" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/osteosarcoma/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/aldoxorubicin/> .